Life Sciences Should Brace For Fla. Rad Source Ruling

Law360, New York ( March 26, 2014, 10:55 PM EDT) -- Some of the most innovative new products arising out of the life sciences industry have passed through multiple hands before reaching physicians, caregivers and patients. Insights and early discoveries in academic laboratories are often validated, translated and tested by small companies and, upon proof-of-concept, those products are then frequently licensed to large, global companies for commercialization. Not surprisingly, intellectual property rights covering those products are conveyed throughout the discovery and development value chain through license arrangements....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!